How much is Oruka Therapeutics worth in 2026?

Oruka Therapeutics has a current valuation of N/A based on their PIPE round and secondary market data.

How much funding has Oruka Therapeutics raised?

Oruka Therapeutics has raised N/A in total funding across 1 funding rounds.

Oruka Therapeutics

Biotechnology

Oruka Therapeutics valuation and funding history | Last updated: September 17, 2025 | 1 funding rounds

Current Valuation

N/A

As of September 17, 2025

Total Funding Raised

N/A

Across 1 round

Last Round

PIPE

$180.0M

Last Funding

Sep 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
September 17, 2025	PIPE	$180.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Oruka Therapeutics is currently valued at N/A as of September 17, 2025.

Track Oruka Therapeutics Valuation Updates

Get notified when Oruka Therapeutics raises new funding or valuation changes

Explore More Data

Detailed analysis for Oruka Therapeutics

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Oruka Therapeutics's valuation history, funding rounds, and growth metrics.

No credit card required

What is Oruka Therapeutics Worth in 2026?

Oruka Therapeutics is a leading private company in the Biotechnology sector. Track Oruka Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Oruka Therapeutics Valuation is Determined

Private company valuations like Oruka Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.